
|Podcasts|November 25, 2021
Episode 96: Forging New Paths In Oncology
Author(s)Elaine Quilici, Miranda Schmalfuhs
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employees during COVID—has played an important role in his professional journey.
Advertisement
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employees during COVID—has played an important role in his professional journey.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
3
Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles
4
Agentic AI and the Future of Commercial Excellence in Life Sciences
5

